The crude material was purified by column chromatography on a 100 g silica column using the Biotage machine and a gradient from 7 to 60 % EtOAc/heptane. 5a eluted first from the column. Pale red solid (0.43 g, 8 min collection time, 42 %). 2, 103.3, 108.1, 118.8, 130.3, 131.4, 138.7, 144.6, 162.6 51.3, 104.7, 109.8, 114.4, 129.8, 132.8, 137.6, 145.6, 161 .9 ppm. HRMS (FAB) calcd for C 9 H 8 O 2 N 2 Br 254.97637, found 254.97638/256.97424.
Ethyl 6-bromopyrazolo[1,5-a]pyridine-3-carboxylate (5c) and ethyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate (5d): The reaction was performed using general flow procedure reacting 3-bromopyridine 2a with ethyl propiolate 4b. The outlet solution (195 mL, collected over 51 mins) was stirred at room temperature while triethylamine (17.5 mL, 126 mmol) was added followed by ethyl propiolate (9.30 mL, 98.4 mmol). The bright red mixture was stirred at room temperature for 15 minutes was concentrated in vacuo to remove the MeCN and then diluted with EtOAc (250 mL) and brine (100 mL). The organic layer was separated and the aqueous phase washed twice more with EtOAc (2 x 200 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated in vacuo to give a dark red oil. The crude material was purified by column chromatography on a 100 g silica column using the Biotage machine and a gradient from 7 to 60 % EtOAc/heptane. 5c eluted first from the column. Pale red solid (1.94 g, 51 min collection time, 11 %). 14.3, 59.8, 103.6, 108.1, 118.9, 130.3, 131.3, 138.6, 144.7, 162 60.1, 105.2, 109.8, 114.3, 129.7, 132.7, 137.4, 145.6, 161.5 Dimethyl pyrazolo[1,5-a]pyridine-3,5-dicarboxylate (5e): The reaction was performed using general flow procedure reacting methyl isonicotinate 2b with methyl propiolate 4a. The outlet solution (163 mL, collected over 43 mins) was stirred at room temperature while triethylamine (14.7 mL, 106 mmol) was added followed by methyl propiolate (7.05 mL, 79.2 mmol). The bright red mixture was stirred at room temperature for 15 minutes and then poured into water (600 mL). The suspension was stirred at room temperature for 10 minutes. The fine white solid formed was removed by filtration and dried at room temperature overnight. White solid (3.0 g, 43 min collection time, 4.2 g/hr, 24 % 4, 52.9, 105.3, 112.8, 119.8, 128.7, 130.5, 139.1, 145.3, 162.5, 164.4 Ethyl 6-((tert-butoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate (5f) and ethyl 4-((tertbutoxycarbonyl)amino)pyrazolo[1,5-a]pyridine-3-carboxylate (5g): The reaction was performed using general flow procedure reacting tert-butyl pyridin-3-ylcarbamate 2c with ethyl propiolate 4b. Due to low solubility, tert-butyl pyridin-3-ylcarbamate was dissolved in MeCN/H 2 O (8:2, 0.5 M) and pumped at 2.45 mL/min. The outlet solution (84 mL, collected over 15 mins, outlet flow rate of 5.614 mL/min) was cooled to 0 °C in an ice bath while triethylamine (9.77 mL, 70.1 mmol) was added followed by ethyl propiolate (3.65 mL, 52.6 mmol). The bright red mixture was stirred at room temperature for 15 minutes. was concentrated in vacuo to remove the MeCN and then diluted with EtOAc (250 mL) and brine (100 mL). The organic layer was separated and the aqueous phase washed twice more with EtOAc (2 x 200 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated in vacuo to give a dark red solid.
The crude material was purified by column chromatography on a 100 g silica column using the Biotage machine and a gradient from 5 to 60 % EtOAc/heptane. 5g eluted first from the column. 80.4, 102.7, 112.4, 115.3, 124.0, 131.0, 133.0, 145.3, 152.3, 165 14.3, 28.0, 59.5, 77.0, 102.7, 109.6, 117.8, 128.9, 136.3, 140.2, 143.9, 152.7, 162.4 
Pyrazolo[1,5-a]pyridin-2-ol (8a):
The reaction was performed using general flow procedure using methyl 2-(pyridin-2-yl)acetate 2d. In this case 2 equivalents of MSH were used so the inlet solution of pyridine was introduced in the second Y-piece at flow rate 0.307 mL/min (i.e. half the flow rate). An additional reaction coil (20 mL, at room temperature) was attached to the existing 10 mL third reactor at 30 °C. The total flow rate at the outlet was 3.48 mL/min. The outlet solution (25 mL, collected over 7.2 mins) was stirred at room temperature while triethylamine (1.23 mL, 126 mmol) was added. The bright red mixture was stirred at room temperature for 15 minutes. was concentrated in vacuo to remove the MeCN and then diluted with EtOAc (100 mL) and brine (100 mL). The organic layer was separated and the aqueous phase washed twice more with EtOAc (2 x 200 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated in vacuo to give a dark red oil. The crude material was purified by column chromatography on a 40 g silica column using the Biotage machine and a gradient from 12 to 100 % EtOAc/heptane. White crystalline solid (126 mg, 7.2 min collection time, 21 %). 9, 109.3, 115.7, 123.7, 128.1, 140.9, 163 .9 ppm. HRMS (FAB) calcd for C 7 H 6 ON 2 157.03723, found 157.03740.
6-Bromopyrazolo[1,5-a]pyridin-2-ol (8b):
The reaction was performed using general flow procedure using methyl 2-(5-bromopyridin-2-yl)acetate 2e. In this case 2 equivalents of MSH were used in order that the inlet solution of pyridine was introduced in the second Y-piece at flow rate 0.307 mL/min (i.e. half the flow rate). An additional reaction coil (20 mL) was attached at room temperature to the existing 10 mL third reactor at 30 °C. The total flow rate at the outlet was 3.481 mL/min. The outlet solution (25 mL, collected over 7.2 mins) was stirred at room temperature while triethylamine (1.23 mL, 126 mmol) was added. The bright red mixture was stirred at room temperature for 15 minutes. was concentrated in vacuo to remove the MeCN and then diluted with EtOAc (100 mL) and brine (100 mL). The organic layer was separated and the aqueous phase washed twice more with EtOAc (2 x 200 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated in vacuo to give a dark red oil. The crude material was purified by trituration in TBME/heptane (1:1, 20 mL) to give a pink crystalline solid (257 6-Bromo-2-fluoropyrazolo[1,5-a]pyridine (9): Methyl 6-bromopyrazolo[1,5-a]pyridine-3-carboxylate 5a (500 mg, 1.96 mmol) was dissolved in DMF (7.84 mL) and stirred at room temperature while Selectfluor (1.39 g, 3.92 mmol) was added in one portion. The pale yellow reaction mixture was heated to 100 °C (in a pre-heated bath) for 20 minutes. The dark red mixture formed showed no remaining starting material by HPLC and so was diluted with EtOAc (100 mL) and water (100 mL). The organic layer was separated and the aqueous phase washed twice more with EtOAc (2 x 200 mL). The combined organic layers were washed with brine (100 mL), dried over anhydrous sodium sulfate and concentrated in vacuo to give methyl 6-bromo-2-fluoropyrazolo [1,5-a] mmol) dissolved in water (4.9 mL) was added dropwise. The dark brown reaction mixture was stirred at 0 °C for 5 minutes after which time HPLC showed no remaining intermediate. The mixture was diluted with TBME (100 mL) and brine (100 mL). The organic layer was separated and the aqueous phase washed twice more with TBME (2 x 200 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated in vacuo to give the product as a brown oil (412 mg, 91% 2   min°C   40  60  80  100  120  140  160  180  200  220  240  260  280  300  320  340  360  380   0  5  10  15  20  25  30  35  40  45  50  55  60  65 1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP026-02 -Comment BR_DESIRED -DMSO,,26.9 C -3.14 1.04 1.04 1.00 1.00 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 (ppm)
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1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP026-02 -Comment BR_DESIRED -DMSO,13C,26.9 C - 1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP026-03 -Comment BR_ISOMER -DMSO,,26.9 C - 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 (ppm)
1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP026-03 -Comment BR_ISOMER -DMSO,13C,26.7 C - 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 (ppm)
1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP026-04 -Comment BR_DESIRED_ET_ESTER -DMSO,13C,26.8 C - 1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP026-01 -Comment CO2ME -DMSO,,26.9 C - 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 (ppm)
1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP026-01 -Comment CO2ME -DMSO,13C,26.8 C - 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 (ppm)
1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP026-06 -Comment NHBOC_DESIRED -DMSO,13C,26.8 C - 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 (ppm)
1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP026-07 -Comment NHBOC_ISOMER -DMSO,13C,26.8 C - 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170 f1 (ppm)
1D -UserID HUMPHCA1 -SampleID HUMPHCA1-005-EXP032-04 -Comment COLUMN -DMSO,13C,26.8 C - 1D -UserID HUMPHCA1 -SampleID HUMPHCA1-004-EXP080-05 -Comment INTRAMOL_CYLISATION -DMSO,,26.8 C - 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 (ppm)
1D -UserID HUMPHCA1 -SampleID HUMPHCA1-004-EXP080-05 -Comment INTRAMOL_CYLISATION -DMSO,13C,26.8 C - 
